Parkinson David Ross 4
4 · ESSA Pharma Inc. · Filed Nov 1, 2022
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Parkinson David Ross
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-06-29+222,500→ 222,500 totalExercise: $3.60Exp: 2032-06-29→ Common Shares (222,500 underlying)
Footnotes (1)
- [F1]One-fourth vests after 12 months from the date of grant with the remaining three-fourths vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month anniversary thereafter.